Equities researchers at S&P Equity Research increased their target price on shares of Johnson & Johnson (NYSE: JNJ) from $78.00 to $88.00 in a report issued on Friday. The firm currently has a “buy” rating on the stock.
Shares of Johnson & Johnson (NYSE: JNJ) traded up 0.11% during mid-day trading on Friday, hitting $79.19. Johnson & Johnson has a one year low of $61.71 and a one year high of $79.10. The stock’s 50-day moving average is currently $76.02. The company has a market cap of $221.4 billion and a P/E ratio of 20.49.
Johnson & Johnson (NYSE: JNJ) last announced its earnings results on Tuesday, January 22nd. The company reported $1.19 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.17 by $0.02. The company had revenue of $17.60 billion for the quarter, compared to the consensus estimate of $17.67 billion. During the same quarter in the prior year, the company posted $1.13 earnings per share. The company’s quarterly revenue was up 8.0% on a year-over-year basis. Johnson & Johnson has set its FY13 guidance at $5.35-5.45 EPS. On average, analysts predict that Johnson & Johnson will post $5.41 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Johnson & Johnson in a research note to investors on Monday. They now have a $82.00 price target on the stock. Separately, analysts at Sanford C. Bernstein reiterated an “outperform” rating on shares of Johnson & Johnson in a research note to investors on Tuesday, March 5th. They now have a $78.00 price target on the stock. Finally, analysts at Jefferies Group reiterated a “hold” rating on shares of Johnson & Johnson in a research note to investors on Friday, February 15th. They now have a $79.00 price target on the stock.
Eleven research analysts have rated the stock with a buy rating, four have given an overweight rating, seven have given a hold rating, and three have assigned a sell rating to the company’s stock. The stock currently has an average rating of “overweight” and a consensus target price of $78.38.
Johnson & Johnson is a holding company. The Company, along with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
